Editor(s):
(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems Propharmex Company, India.
Reviewers:
(1) Samuel D Prien, Texas Tech University Health Sciences Center, United States.
(2) Jesús G. Rodríguez Diego, Universidad Autónoma Metropolitana, (UAM) – Unidad Xochimilco, México.
Additional Reviewers:
(1) Berhanu Senbeta Deriba, Salale University, Ethiopia.
(2) Fevzi Cengiz, Tinaztepe University, Turkey.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.25/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Samuel D Prien, United States) | File 1 | File 2
Stage 2 | Peer review report_2 (Jesús G. Rodríguez Diego, México) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA